Jergensen Joshua sold $1.7M of PACS
Jergensen Joshua (President & COO) sold 40,000 shares of PACS Group, Inc. (PACS) at an average of $43.13 ($43.08–$43.62, $1.73M total) across 2 trades on 2026-09-16 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Insider sale of $1.7M may slightly affect short‑term sentiment but unlikely to drive price.
Market read
A modest insider sell; traders may monitor for any follow‑up activity.
What to watch
Potential upcoming corporate actions or personal liquidity needs not disclosed.
Background
SEC Form 4 filing provides primary source disclosure of insider transactions.
Ticker impact
Form 4 disclosed President & COO sold $1.7M of shares via 10b5‑1 plan.
Potential slight downward pressure; unlikely to move price materially.
Sale represents ~0.07% of total shares; typical for diversification, limited impact.
Market effects
Minimal effect on healthcare services sector; no broader trend indicated.
Limited to US markets where PACS trades.
Low; isolated insider transaction.
Counterpoint
Sale could be routine diversification rather than a negative signal.
Key entities
- CompanyPACS Group, Inc.
Healthcare services provider listed on NYSE under ticker PACS.
- IndividualJergensen Joshua
President & COO of PACS, reporting the insider sale.
